Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol

Biotechnology Companies

Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United States
32.9B
---
+10.08%
United StatesCRL
Charles River Laboratories International Inc
18.0B
46.3x
+17.94%
United StatesEXEL
Exelixis Inc
5.0B
31.1x
---
United StatesGILD
Gilead Sciences Inc
87.3B
11.9x
-61.76%
United StatesICLR
ICON PLC
22.2B
69.3x
+9.44%
United StatesIQV
IQVIA Holdings Inc
50.1B
66.6x
-14.23%
United StatesLGND
Ligand Pharmaceuticals Inc
2.5B
37.7x
---
United StatesMRVI
Maravai LifeSciences Holdings Inc
10.9B
34.7x
---
United StatesNBIX
Neurocrine Biosciences Inc
7.6B
17.4x
---
United StatesSYNH
Syneos Health Inc
10.1B
40.8x
-1.24%
United StatesUTHR
United Therapeutics Corp
8.4B
18.9x
-1.93%
United StatesVNDA
Vanda Pharmaceuticals Inc
903.7M
26.8x
---
United StatesVRTX
Vertex Pharmaceuticals Inc
51.8B
24.4x
---
United StatesABCM
Abcam PLC
5.1B
229.7x
---
United StatesANAB
AnaptysBio Inc
830.7M
98.1x
---
United StatesAVIR
Atea Pharmaceuticals Inc
669.8M
29.6x
---
United StatesCDMO
Avid Bioservices Inc
1.8B
312.9x
---
United StatesBLCM
Bellicum Pharmaceuticals Inc
14.2M
1.5x
---
United StatesTECH
Bio-Techne Corp
17.9B
105.4x
+4.37%
United StatesBNTX
BioNTech SE
83.4B
10.3x
---
United StatesBSPM
Biostar Pharmaceuticals Inc
530.0
0.0x
---
United StatesBRGC
BrightRock Gold Corp
22.0M
458.3x
---
United StatesCARA
Cara Therapeutics Inc
658.1M
28.1x
---
United StatesCPRX
Catalyst Pharmaceuticals Inc
707.4M
17.6x
---
United StatesCELU
Celularity Inc
749.4M
20.7x
---
United StatesCSBR
Champions Oncology Inc
109.3M
1,085.3x
---
United StatesCLGN
Collplant Biotechnologies Ltd
167.6M
80.3x
---
United StatesCRVS
Corvus Pharmaceuticals Inc
144.3M
47.3x
---
United StatesCRSP
CRISPR Therapeutics AG
5.4B
14.7x
---
United StatesDNLI
Denali Therapeutics Inc
5.2B
1,143.4x
---
United StatesCRXM
Gene Biotherapeutics Inc
60.0
0.0x
---
United StatesGMAB
Genmab A/S
24.5B
56.1x
---
United StatesHALB
Halberd Corp
9.6M
8.1x
---
United StatesHALO
Halozyme Therapeutics Inc
4.6B
11.6x
---
United StatesIDRA
Idera Pharmaceuticals Inc
31.7M
-0.8x
---
United StatesICCC
ImmuCell Corp
69.7M
4,265.4x
---
United StatesIMUN
Immune Therapeutics Inc
766.2K
-1.0x
---
United StatesINCY
Incyte Corp
14.5B
27.2x
---
United StatesIRWD
Ironwood Pharmaceuticals Inc
1.8B
3.4x
---
United StatesITOS
Iteos Therapeutics Inc
1.2B
118.6x
---
United StatesLJPC
La Jolla Pharmaceutical Co
103.5M
11.7x
---
United StatesMEDP
Medpace Holdings Inc
7.4B
42.6x
---
United StatesMRNA
Moderna Inc
124.4B
18.8x
---
United StatesOPNT
Opiant Pharmaceuticals Inc
154.7M
675.9x
---
United StatesOVID
Ovid Therapeutics Inc
218.6M
1.8x
---
United StatesPPD
PPD Inc
16.6B
47.2x
---
United StatesPRTA
Prothena Corporation PLC
2.2B
45.0x
---
United StatesQGEN
Qiagen NV
12.5B
21.2x
+22.05%
United StatesQSAM
Qsam Biosciences Inc
11.0M
1.4x
---
As of 2021-12-04

Biotechnology

The Biotechnology industry consists of companies engaged in the research and development of new drugs, medical devices and procedures. The industry includes the manufacturing and marketing of drugs as a result of direct research and development. The Biotechnology industry excludes drug manufacturers without research and development operations, and advanced medical equipment wholesalers.

Company Strategies

Companies that have maintained their dividend in the face of falling share price lead to high dividend yields. Attention should be paid to the sustainability of these future payments. Generally companies with high dividend yields are mature, stable companies.

Company Strategies Table
CompanyDividend Yield
United StatesGRFS
Grifols SA - ADR
6.26%
United StatesGILD
Gilead Sciences, Inc.
4.08%
United StatesTECH
BIO-TECHNE Corp
0.28%
United StatesCDMO
Avid Bioservices Inc
---
United StatesXOMA
XOMA Corp
---
At 2021-12-04 09:30 PM ET Data delayed at least 15 minutes.